Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl (Text with EEA relevance)
2016年4月8日委员会实施条例(EU)2016/549修订了第540/2011号实施条例(EU) 涉及延长活性物质苯达松、cyhalofop butyl、diquat、法莫沙酮、氟米恶嗪、DPX KE 459(甲基氟吡嘧磺隆)、甲霜灵-M、picolinafen、prosulfuron、pymetrozine、 噻菌灵和甲基噻吩磺隆(与欧洲经济区相关的文本)
发布日期:
2016-04-08
2016年4月8日委员会实施条例(EU)2016/549修订了第540/2011号实施条例(EU),涉及延长活性物质苯达松、cyhalofop butyl、diquat、法莫沙酮、氟米恶嗪、DPX KE 459(甲基氟吡嘧磺隆)、甲霜灵-M、picolinafen、prosulfuron、pymetrozine、,噻菌灵和甲基噻吩磺隆(与欧洲经济区相关的文本)
Commission Implementing Regulation (EU) 2016/549 of 8 April 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bentazone, cyhalofop butyl, diquat, famoxadone, flumioxazine, DPX KE 459 (flupyrsulfuron-methyl), metalaxyl-M, picolinafen, prosulfuron, pymetrozine, thiabendazole and thifensulfuron-methyl (Text with EEA relevance)